Also, the Toll-like receptor signaling pathway is involved in cancer progression and metastasis.[34] Thus, STAT2 might play an important function in immune escape in the KIRC microenvironment suggesting that STAT2 is a potential immune checkpoint inhibitor for KIRC therapy. This evidence concerns the gene STAT2 and cancer.